Literature DB >> 30463137

H2O2-assisted photoelectrocatalytic degradation of Mitoxantrone using CuO nanostructured films: Identification of by-products and toxicity.

Ana Paula Pereira da Rosa1, Rodrigo Pereira Cavalcante1, Débora Antonio da Silva1, Lucas de Melo da Silva1, Thalita Ferreira da Silva1, Fábio Gozzi1, Enda McGlynn2, Anita Brady-Boyd3, Gleison Antônio Casagrande1, Heberton Wender4, Silvio César de Oliveira1, Amilcar Machulek Junior5.   

Abstract

CuO nanostructured thin films supported on silicon with 6.5 cm2 area (geometric area greater than the studies reported in the literature) were synthesized by a chemical bath deposition technique. The electrodes were characterized by MEV, XRD, XPS, contact angle, cyclic voltammetry and electrochemical impedance spectroscopy analyses. To evaluate the photoelectrochemical properties of the CuO films, photocurrent-voltage measurements were performed using linear voltammetry. The catalytic activities of CuO nanostructures were evaluated by monitoring photodegradation of Mitoxantrone (MTX) under UV-A light irradiation. The method of photoelectrocatalysis (PEC), applying a voltage of 1.5 V and assisted by adding H2O2, was undertaken. To the best of our knowledge, no studies on the degradation of anticancer agents using PEC process have been found in the literature. For comparison purposes, experiments were performed under the same conditions by assisted photocatalysis (PC) with H2O2 and direct photolysis. CuO deposits consist of a needle-like morphology. The presence of CuO in the tenorite phase was evidenced by XRD and the XPS spectra showed the presence of copper(II) oxide. The increase in current under illumination shows that CuO exhibits photoactivity. The PEC system showed a 75% level of MTX degradation, while the level achieved using PC was 50%. Under UV-A light alone only 3% removal was obtained after 180 min. Up to 10 by-products were identified by chromatography-mass spectrometry (LC-MS) with m/z values ranging between 521 and 285 and a plausible degradation route has been proposed. It is worth mentioning that 9 by-products identified in this work, were not found in the literature in other studies of degradation or products generated as metabolites. The toxicity tests of MTX before and after PEC treatment with Artemia Salina and Allium cepa showed a decrease in the acute toxicity of the medium as the antineoplastic was degraded.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Anticancer drug; Chemical synthesis; CuO/Si heterojunctions; Degradation pathways; Needle-like CuO nanostructures; Photoelectrocatalytic activity

Mesh:

Substances:

Year:  2018        PMID: 30463137     DOI: 10.1016/j.scitotenv.2018.10.173

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   7.963


  3 in total

Review 1.  Supported nanostructured photocatalysts: the role of support-photocatalyst interactions.

Authors:  Sajjad Ullah; Elias P Ferreira-Neto; Abrar A Khan; Isaac P M Medeiros; Heberton Wender
Journal:  Photochem Photobiol Sci       Date:  2022-09-30       Impact factor: 4.328

2.  Synthesis and Characterization of N and Fe-Doped TiO2 Nanoparticles for 2,4-Dimethylaniline Mineralization.

Authors:  Emerson Faustino; Thalita Ferreira da Silva; Rebeca Fabbro Cunha; Diego Roberto Vieira Guelfi; Priscila Sabioni Cavalheri; Silvio César de Oliveira; Anderson Rodrigues Lima Caires; Gleison Antonio Casagrande; Rodrigo Pereira Cavalcante; Amilcar Machulek Junior
Journal:  Nanomaterials (Basel)       Date:  2022-07-24       Impact factor: 5.719

3.  Environmentally Safe Photodynamic Control of Aedes aegypti Using Sunlight-Activated Synthetic Curcumin: Photodegradation, Aquatic Ecotoxicity, and Field Trial.

Authors:  Alessandra R Lima; Cicera M Silva; Lucas M da Silva; Amilcar Machulek; Antônio P de Souza; Kleber T de Oliveira; Larissa M Souza; Natalia M Inada; Vanderlei S Bagnato; Samuel L Oliveira; Anderson R L Caires
Journal:  Molecules       Date:  2022-09-04       Impact factor: 4.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.